Papers
25
Total Citations
2,132
H-Index
19
About
Stuart R. Lipsitz is a leading health services researcher whose work has fundamentally shaped our understanding of the costs, outcomes, and comparative effectiveness of surgical technologies, particularly in urologic oncology. His research focuses on the rapid adoption of expensive new surgical platforms, such as robotic-assisted surgery, and their real-world impact on patient morbidity and healthcare economics. With highly cited papers accumulating thousands of citations, Lipsitz has provided critical, population-based evidence that challenges the uncritical embrace of new technologies. His landmark 2011 study on the cost implications of treating prostate cancer, with 307 citations, revealed that the rapid shift to costlier therapies like IMRT and robotic prostatectomy was not always matched by superior outcomes. Similarly, his 2012 comparative effectiveness study (289 citations) demonstrated that robotic surgery offered no clear advantage over open or laparoscopic approaches for many urological procedures, while significantly driving up costs. Beyond cost analysis, Lipsitz has made notable technical contributions, including the development of nerve-sparing techniques and barbed suture methods for robotic prostatectomy, which have improved surgical precision and patient recovery. His rigorous, data-driven approach continues to inform clinical decision-making and healthcare policy, making him a pivotal voice in the debate over surgical innovation and value-based care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10Comparative effectiveness of robot-assisted vs. open radical cystectomy75 citations · 2017